SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

update

Moving EMA to DG Enterprise will increase risk of adverse events says NGO

Moving EMA to DG Enterprise will increase risk to patients says NGO

Shifting EMA oversight to DG Enterprise and Industry will put patients at greater risk of adverse events according to NGO Health Action International, which suspects EFPIA “had a hand” in European Commission reshuffle plan.

Related news

News in brief

Hospira has invested 15m AUD ($14m) in a Victoria injectables plant it says will continue to make drugs for export despite the economic downturn and strong Australian dollar.

The US FDA has warned the public not to use any sterile medicines made by Downing-owned NuVision Pharmacy, Texas, which failed to comply with a recall order.

On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a look at the pharma inventions Scotland gave the world.

Mannkind says Sanofi could become a second API supplier for its recently approved inhalable insulin drug Afrezza following its commercialisation partnership last month.

Global Industry News

'Fastest way to biosimilar approval? As the CRO flies,' says industry group from BioPharma-Reporter.com

Almost all of the biosimilars currently approved have been developed using a third-party research organisation according to a survey from the Association of Clinical Research Organizations (ACRO).

Merck KGaA is latest bi-curious antibody developer in ADC deal with Sutro from BioPharma-Reporter.com

Merck KGaA has partnered with bispecific antibody firm Sutro Biopharma to develop and produce antibody drug conjugates (ADCs).

M&As discussed: Do merged CROs/CMOs equal less than the sum of their parts? from Outsourcing-Pharma.com

Suppliers Albemarle, Siegfried USA and Johnson Matthey join CROs, CMOs and other leaders of the services sector in New Jersey, US this week to discuss all things outsourcing.

Dispatches from ChemOutsourcing

CMO consolidation: Do biopharma partners see any benefits? from Outsourcing-Pharma.com

As contract manufacturers continue to consolidate , some in the industry are questioning whether the resulting companies have the ability to offer the same services as the former individual companies. 

Biosimilar mAbs to cut Europe's healthcare bill by €20bn by 2020 from BioPharma-Reporter.com

At present Biosimilars save Europe roughly €2.40 per person, or €1.8bn a year, but by 2020 follow-on mAbs alone will shave €20bn off the continent’s healthcare bill according to researchers.

CRL on the prowl for Chinese M&As in world’s future science hub from BioPharma-Reporter.com

Charles River Labs (CRL) has singled out China as an area of “disproportionate growth” in biologics R&D and says it is on the hunt for preclinical acquisitions in the region.

DHL and Octopharma open cold-chain logistics centre in Germany from Outsourcing-Pharma.com

In a venture with plasma products manufacturer Octopharma, DHL has opened a €3.4m ($4.4m) cold-chain logistics centre in Germany for the pharma and life sciences industries.

Spotlight

Ben venue fallout continues to cause headache for Boehringer Ingelheim

Ben venue fallout continues to cause headache for Boehringer Ingelheim

Divested sterile manufacturer Ben Venue has continued to cause trouble for Boehringer Ingelheim with a second recall...

‘James bond’-like tech is the end to overdoses, says formulation firm

‘James bond’-like tech is the end to overdoses, says formulation firm

Canadian drugmaker Intellipharmaceutics has developed a kill-switch formulation it says will prevent drug misuse and accidental overdoses.

Find other oral forms for tablet-hating patients, drugmakers told

Find other oral forms for tablet-hating patients, drugmakers told

Pharma firms must provide imaginative solid dosage alternatives to tablets and capsules, says research claiming more than...

Gangsters imported fake drugs from Asia says Europol

Gangsters imported fake drugs from Asia says Europol

Millions of fake pharmaceuticals seized earlier today were imported from Asia by an organised crime group that...

Compounding the problem: US warns two more pharmacies

Compounding the problem: US warns two more pharmacies

The US FDA has criticised the Compounding Shop and Zion Rx Formulations Services for making unapproved and...

Is Pfizer now eyeing up Actavis three months after failed AZ bid?
INFOGRAPHIC

Is Pfizer now eyeing up Actavis three months after failed AZ bid?

Pfizer is rumoured to be eyeing up Actavis three months after failing to woo AstraZeneca in a...

Key Industry Events

 

Access all events listing

Our events, Events from partners...